© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
Top Medical News
BioNTech Says Variant COVID-19 Vaccines May Be Available as Early as October
August 9th 2022
The company and its partner, Pfizer, are preparing for the potential launch of 2 variant-adapted bivalent COVID-19 vaccines assuming authorizations from FDA and EMA.
FDA Committee Will Meet Next Month for Potential RBX2660 Approval
August 9th 2022
An FDA advisory committee will meet on September 22, 2022 to decide whether to approve a biologics license application (BLA) for Ferring’s recurrent C difficile biotherapeutic, RBX2660.
Incidence of STIs Stabilized Among Gay and Bisexual Men Using HIV PrEP
August 9th 2022
After widespread implementation of HIV pre-exposure prophylaxis (PrEP) among gay and bisexual men in Australia, population-level incidence of chlamydia and gonorrhea stabilized, allaying fears that PrEP would lead to a rise in STIs, a recent study found.
CDC: People with Untreated or Advanced HIV May be at Risk for Severe Monkeypox
August 8th 2022
The latest MMWR offered guidance to these high-risk groups.
CDC Sends Small Team to Investigate Polio in New York State
August 8th 2022
A single case was identified last month, and wastewater samples shows the potential for more cases.
10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups
August 2nd 2022
Expanding Medicaid and reducing stigma can bolster equitable HIV PrEP access, Dr. Patrick Sullivan says.
Biktarvy Effective for HIV Patients Coinfected With Hepatitis B
August 1st 2022
At AIDS 2022, Gilead presented data suggesting Biktarvy was a safe and effective complete HIV treatment regimen, including for those coinfected with hepatitis B.
Fostemsavir Improves Outcomes for Treatment-Resistant HIV Patients
July 30th 2022
After 5 years of treatment, fostemsavir improved immunologic response and virologic outcome in patients with highly resistant HIV infection.
The Patient Impact of CDI, Preventing Reoccurrence
June 1st 2022
A clinician discusses the disease burden of reoccurring CDI, but sees a silver lining in the new investigational therapies potentially changing the treatment paradigm for the better.
August 7, 2022 2:53 PM
By John Parkinson
August 5, 2022 5:00 PM
By Contagion Editorial Team
August 5, 2022 2:02 PM
By John Parkinson
August 4, 2022 7:42 PM
By John Parkinson
August 4, 2022 5:00 PM
By John Parkinson
August 4, 2022 1:00 PM
By John Parkinson
August 3, 2022 8:11 PM
By John Parkinson
August 3, 2022 12:57 PM
By John Parkinson
August 2, 2022 8:30 PM
By Nina Cosdon
August 2, 2022 5:00 PM
By Kenneth Bender, PharmD, MA
